{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:36:42Z","timestamp":1793421402417,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jhepr.2023.100721","type":"journal-article","created":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T14:39:26Z","timestamp":1678027166000},"page":"100721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver disease"],"prefix":"10.1016","volume":"5","author":[{"given":"Jihye","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2557-5911","authenticated-orcid":false,"given":"Hyunji","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5471-7790","authenticated-orcid":false,"given":"Ha Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100721_bib1","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/j.gastro.2016.03.005","article-title":"Contribution of alcoholic and nonalcoholic fatty liver disease to the burden of liver-related morbidity and mortality","volume":"150","author":"Younossi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100721_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3350\/cmh.2019.0065","article-title":"Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017","volume":"26","author":"Park","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100721_bib3","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"392","author":"Griswold","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2023.100721_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100721_bib5","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2023.100721_bib6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jhep.2019.05.020","article-title":"Natural history of histologically proven alcohol-related liver disease: a systematic review","volume":"71","author":"Parker","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100721_bib7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fmed.2020.00448","article-title":"Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities","volume":"7","author":"Idalsoaga","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jhepr.2023.100721_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cgh.2019.05.004","article-title":"Alcoholic and nonalcoholic fatty liver disease and incident hospitalization for liver and cardiovascular diseases","volume":"18","author":"Chang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100721_bib9","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1136\/gutjnl-2021-325724","article-title":"Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort","volume":"71","author":"Simon","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100721_bib10","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/hep.29631","article-title":"Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population","volume":"67","author":"Aberg","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100721_bib11","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.31014","article-title":"Effect of metabolic traits on the risk of cirrhosis and hepatocellular cancer in nonalcoholic fatty liver disease","volume":"71","author":"Kanwal","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100721_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100721_bib13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/hep.32499","article-title":"Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?","volume":"76","author":"Younossi","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100721_bib14","first-page":"1423","article-title":"MAFLD and excessive alcohol consumption are both independent risk factors for mortality","volume":"76","author":"van Kleef","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100721_bib15","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cgh.2022.04.012","article-title":"Nomenclature dilemma of metabolic associated fatty liver disease (MAFLD): considerable proportions of MAFLD are metabolic healthy","volume":"21","author":"Park","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100721_bib16","doi-asserted-by":"crossref","first-page":"8393","DOI":"10.3748\/wjg.v20.i26.8393","article-title":"Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease","volume":"20","author":"Toshikuni","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100721_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.21037\/tgh.2019.10.02","article-title":"Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis","volume":"5","author":"Sharma","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100721_bib18","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/gut.2003.019984","article-title":"Long term prognosis of fatty liver: risk of chronic liver disease and death","volume":"53","author":"Dam-Larsen","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100721_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-230X-14-166","article-title":"Long term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease","volume":"14","author":"Haflidadottir","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100721_bib20","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1080\/00365520903171284","article-title":"Final results of a long-term, clinical follow-up in fatty liver patients","volume":"44","author":"Dam-Larsen","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100721_bib21","first-page":"64","article-title":"Comorbidities and nonalcoholic fatty liver disease: the chicken, the egg, or both?","volume":"36","author":"Glass","year":"2019","journal-title":"Fed Pract"},{"key":"10.1016\/j.jhepr.2023.100721_bib22","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.3390\/ijerph17082825","article-title":"Comorbidities and outcome of alcoholic and non-alcoholic liver cirrhosis in Taiwan: a population-based study","volume":"17","author":"Yang","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jhepr.2023.100721_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41591-021-01594-1","article-title":"The need for reporting guidelines for early phase dose-finding trials: dose-finding CONSORT extension","volume":"28","author":"Yap","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2023.100721_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/amiajnl-2011-000376","article-title":"Validation of a common data model for active safety surveillance research","volume":"19","author":"Overhage","year":"2012","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.jhepr.2023.100721_bib25","first-page":"574","article-title":"Observational health data sciences and informatics (OHDSI): opportunities for observational researchers","volume":"216","author":"Hripcsak","year":"2015","journal-title":"Stud Health Technol Inform"},{"key":"10.1016\/j.jhepr.2023.100721_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4258\/hir.2016.22.1.54","article-title":"Conversion and data quality assessment of electronic health record data at a Korean tertiary teaching hospital to a common data model for distributed network research","volume":"22","author":"Yoon","year":"2016","journal-title":"Healthc Inform Res"},{"key":"10.1016\/j.jhepr.2023.100721_bib27","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1136\/gutjnl-2020-323845","article-title":"Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea","volume":"70","author":"Seo","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100721_bib28","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.1038\/s41598-021-86197-z","article-title":"Incidence and management patterns of alcohol-related liver disease in Korea: a nationwide standard cohort study","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2023.100721_bib29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1373\/49.4.624","article-title":"LOINC, a universal standard for identifying laboratory observations: a 5-year update","volume":"49","author":"McDonald","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.jhepr.2023.100721_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0038-1667077","article-title":"Recent developments in clinical terminologies - SNOMED CT, LOINC, and RxNorm","volume":"27","author":"Bodenreider","year":"2018","journal-title":"Yearb Med Inform"},{"key":"10.1016\/j.jhepr.2023.100721_bib31","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1038\/s41598-022-08595-1","article-title":"Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer\u2019s dementia using OMOP CDM","volume":"12","author":"Byun","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2023.100721_bib32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/STROKEAHA.120.030433","article-title":"Severity of nonalcoholic fatty liver disease and risk of future ischemic stroke events","volume":"52","author":"Xu","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jhepr.2023.100721_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021654","article-title":"Nonalcoholic fatty liver disease and risk of heart failure among medicare beneficiaries","volume":"10","author":"Fudim","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jhepr.2023.100721_bib34","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/liv.14461","article-title":"Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation","volume":"40","author":"Cai","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100721_bib35","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01923-2016","article-title":"Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease","volume":"49","author":"Viglino","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhepr.2023.100721_bib36","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1136\/gut.2011.242016","article-title":"Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100721_bib37","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jhep.2010.11.007","article-title":"Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?","volume":"54","author":"Targher","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100721_bib38","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1002\/hep.31612","article-title":"Association of metabolic risk factors with risks of cancer and all-cause mortality in patients with chronic hepatitis B","volume":"73","author":"Lee","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100721_bib39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jhepr.2019.07.009","article-title":"Public health policies and alcohol-related liver disease","volume":"1","author":"Ventura-Cots","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100721_bib40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cld.1061","article-title":"Global epidemiology of chronic liver disease","volume":"17","author":"Cheemerla","year":"2021","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100721_bib41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3350\/cmh.2020.0042","article-title":"Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?","volume":"26","author":"Shim","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100721_bib42","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","article-title":"Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100721_bib43","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.cgh.2018.11.033","article-title":"Effects of alcohol consumption and metabolic syndrome on mortality in patients with nonalcoholic and alcohol-related fatty liver disease","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100721_bib44","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/liv.14754","article-title":"The combined effect of alcohol and body mass index on risk of chronic liver disease: a systematic review and meta-analysis of cohort studies","volume":"41","author":"Glyn-Owen","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100721_bib45","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/apt.16575","article-title":"Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations","volume":"54","author":"Polyzos","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100721_bib46","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1093\/eurheartj\/ehab315","article-title":"Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study","volume":"42","author":"Lee","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jhepr.2023.100721_bib47","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.jacc.2016.08.074","article-title":"Alcohol and atrial fibrillation: a sobering review","volume":"68","author":"Voskoboinik","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhepr.2023.100721_bib48","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3350\/cmh.2022.0155","article-title":"Does nonalcoholic fatty liver disease predispose patients to carotid arteriosclerosis and ischemic stroke?","volume":"28","author":"Jin","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100721_bib49","first-page":"603","article-title":"Nonalcoholic fatty liver disease and atrial fibrillation: possible pathophysiological links and therapeutic interventions","volume":"33","author":"Haghbin","year":"2020","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100721_bib50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fneur.2019.00375","article-title":"The paradoxical protective effect of liver steatosis on severity and functional outcome of ischemic stroke","volume":"10","author":"Baik","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.jhepr.2023.100721_bib51","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/ene.15277","article-title":"Non-alcoholic fatty liver disease and stroke: a Mendelian randomization study","volume":"29","author":"Wu","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jhepr.2023.100721_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3350\/cmh.2017.0079","article-title":"Epidemiology of alcoholic liver disease in Korea","volume":"24","author":"Jang","year":"2018","journal-title":"Clin Mol Hepatol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923000526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923000526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:31:19Z","timestamp":1762900279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923000526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2589555923000526"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100721","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100721"}}